Company: PACB
Filing Date: 2025-02-13
Form Type: 8-K
Source: 0001299130-25-000033
Chunk: 0

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-02-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On February 13, 2025, Pacific Biosciences of California, Inc. (the “ Company”) announced its financial results for its fourth fiscal quarter and year ended December 31, 2024. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

This information, as well as Exhibit 99.1, is intended to be furnished under Item 2.02 of Form 8-K, “ Results of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.